Should We Be Treating ICI Pneumonitis Longer? TWPCCM

This week on This Week in Pulmonary and Critical Care Medicine (TWPCCM), we review three important new studies that challenge everyday clinical decisions in pulmonary and critical care practice. • Rocuronium dose and first-attempt intubation success in the critically ill: Secondary analysis of the DEVICE and PREOXI trials. American Journal of Respiratory and Critical Care Medicine. • Three versus six weeks of corticosteroids for mild immune checkpoint inhibitor pneumonitis. American Journal of Respiratory and Critical Care Medicine. • Consensus criteria for invasive pulmonary aspergillosis in hospitalized COPD exacerbations. American Journal of Respiratory and Critical Care Medicine. If you enjoyed this evidence-based review, please like, subscribe, and share the episode with colleagues. Your support helps us continue delivering concise, clinically relevant updates for busy pulmonologists, intensivists, fellows, residents, and advanced practice providers.